<DOC>
	<DOCNO>NCT01992094</DOCNO>
	<brief_summary>Evaluate safety immunogenicity three influenza vaccine adult 18 year age .</brief_summary>
	<brief_title>Safety Immunogenicity Three Influenza Vaccines Adults Ages 18 Older</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Male female age 18 year old . 2 . Individuals give write informed consent , comply study procedure , available followup . 1 . Individuals recently vaccinate influenza 2 . Subjects contraindication receive influenza vaccine 3 . Please contact site additional eligibility criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Novartis</keyword>
	<keyword>Adults</keyword>
</DOC>